Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years

Intestinal Research · Published 2026-07-10 · DOI 10.5217/ir.2025.00285

Free full text

Authors (9)

Byong Duk Ye, Ken Sugimoto, Jae Hee Cheon, Christopher Gasink, Yuya Imai, Bryan Wahking, Jianmin Zhuo, Shiho Kawamura, Toshifumi Hibi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ye, B., Sugimoto, K., Cheon, J., et al. (2026). Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years. Intestinal Research. https://doi.org/10.5217/ir.2025.00285

Related articles